agilon health (NYSE:AGL) Upgraded at Citigroup

Citigroup upgraded shares of agilon health (NYSE:AGL) from a sell rating to a neutral rating in a report released on Friday, MarketBeat reports. Citigroup currently has $2.25 target price on the stock, up from their previous target price of $1.75.

Several other equities research analysts have also issued reports on AGL. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Macquarie initiated coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Finally, Evercore ISI cut their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $3.98.

agilon health Stock Performance

agilon health stock opened at $2.42 on Friday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a 50 day moving average of $2.07 and a 200-day moving average of $3.73. The stock has a market cap of $997.08 million, a P/E ratio of -2.57 and a beta of 0.53. agilon health has a 52 week low of $1.50 and a 52 week high of $8.20.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the firm posted ($0.06) EPS. On average, analysts expect that agilon health will post -0.52 EPS for the current fiscal year.

Insider Activity

In other news, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Diana Mckenzie acquired 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was purchased at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 90,000 shares of company stock valued at $198,100. Company insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. AQR Capital Management LLC increased its holdings in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its holdings in shares of agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the last quarter. Citigroup Inc. raised its position in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of agilon health during the second quarter worth $1,849,000. Finally, Geode Capital Management LLC lifted its holdings in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after purchasing an additional 84,889 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.